Plant production of high affinity nanobodies that block SARS-CoV-2 spike protein binding with its receptor, human angiotensin converting enzyme
M. Pitino, L. A. Fleites, L. Shrum, M. Heck, R. G. Shatters
This study produces nanobodies in plants that block SARS-CoV-2 spike protein binding to ACE2, offering a scalable method for therapeutic development.
bioRxiv · Sep 3, 2022Bioengineering